About Us Products Pipeline Investors & News Careers Contact Us Making a Difference in People's Lives A fully-integrated biopharmaceutical company driven by innovation © 2021 Osmotica Pharmaceuticals plc. All Rights Reserved A public limited company Registered in Ireland Registration Number: 607944 Registered office: 25-28 North Wall Quay, Dublin 1, Ireland Terms of Use Privacy Policy

About Us Products Pipeline Investors & News Careers Contact Us About Us Leadership About Us Osmotica Pharmaceuticals is a Fully-Integrated Biopharmaceutical Company Overview Osmotica Pharmaceuticals plc is a fully-integrated biopharmaceutical company focused on developing, manufacturing and commercializing specialty products. Our diversified product portfolio in the specialty neurology and women's health space, together with our non-promoted complex formulations of generic drugs, form the foundation of our unwavering commitment to improve patients' lives. © 2021 Osmotica Pharmaceuticals plc. All Rights Reserved A public limited company Registered in Ireland Registration Number: 607944 Registered office: 25-28 North Wall Quay, Dublin 1, Ireland Terms of Use Privacy Policy

About Us Products Pipeline Investors & News Careers Contact Us Company Profile Press Releases News Latest News Releases Company Profile Osmotica Pharmaceuticals plc is a fully-integrated biopharmaceutical company focused on developing, manufacturing and commercializing specialty products. Our diversified product portfolio in the specialty neurology and women's health space, together with our non-promoted complex formulations of generic drugs, form the foundation of our unwavering commitment to improve patients' lives. © 2021 Osmotica Pharmaceuticals plc. All Rights Reserved Terms of Use Privacy Policy

About Us Products Pipeline Investors & News Careers Contact Us Company Profile Press Releases News Latest News Releases Press Releases February 19, 2018 FDA Approves Osmotica Pharmaceutical's Once-Daily OSMOLEX ERTM (amantadine) extended-release tablets for the treatment of Parkinson's Disease and Drug-Induced Extrapyramidal Reactions in Adults © 2021 Osmotica Pharmaceuticals plc. All Rights Reserved Terms of Use Privacy Policy